Search

Displaying results 6371 - 6380 of 10000 in total
  1. Drug

    Canlitinib

    go.drugbank.com/drugs/DB21656
    Experimental

    The usage of the INN stem '-tinib' in the name indicates that Canlitinib is a tyrosine kinase inhibitor. Canlitinib has a monoisotopic molecular weight of 619.21 Da.

  2. Drug

    Labuxtinib

    go.drugbank.com/drugs/DB21658
    Experimental

    The usage of the INN stem '-tinib' in the name indicates that Labuxtinib is a tyrosine kinase inhibitor. Labuxtinib has a monoisotopic molecular weight of 377.13 Da.

  3. Drug

    Trimoprostil

    go.drugbank.com/drugs/DB19935
    Experimental

    The usage of the INN stem '-prostil' in the name indicates that Trimoprostil is a anti-ulcer prostaglandin. Trimoprostil has a monoisotopic molecular weight of 378.28 Da.

    Categories: Prostaglandins E
  4. Drug

    Nifuroquine

    go.drugbank.com/drugs/DB19999
    Experimental

    The usage of the INN stem 'nifur-' in the name indicates that Nifuroquine is a 5-nitrofuran derivative. Nifuroquine has a monoisotopic molecular weight of 300.04 Da.

  5. Drug

    Semparatide

    go.drugbank.com/drugs/DB20016
    Experimental

    The usage of the INN stem '-paratide' in the name indicates that Semparatide is a parathyroid hormone analogue. Semparatide has a monoisotopic molecular weight of 4002.26 Da.

  6. Drug

    Brobactam

    go.drugbank.com/drugs/DB20131
    Experimental

    The usage of the INN stem '-bactam' in the name indicates that Brobactam is a ẞ-lactamase inhibitor. Brobactam has a monoisotopic molecular weight of 278.96 Da.

  7. Drug

    Fandosentan

    go.drugbank.com/drugs/DB20193
    Experimental

    The usage of the INN stem '-entan' in the name indicates that Fandosentan is a endothelin receptor antagonist. Fandosentan has a monoisotopic molecular weight of 517.08 Da.

  8. Drug

    HLX70

    go.drugbank.com/drugs/DB16509
    Investigational

    HLX70, a recombinant humanized anti-S protein monoclonal antibody intended for intravenous infusion, was under investigation in clinical trials NCT05429385 and NCT04561076 to evaluate its safety and pharmacokinetics … in healthy adult volunteers.

  9. Drug

    Eptotermin alfa

    go.drugbank.com/drugs/DB11631
    ApprovedWithdrawn

    Eptotermin alfa is an ingredient in the EMA-withdrawn product Osigraft.

  10. Drug

    2-chloroethyl-3-sarcosinamide-1-nitrosourea

    go.drugbank.com/drugs/DB11688
    Investigational

    2-chloroethyl-3-sarcosinamide-1-nitrosourea has been used in trials studying the treatment of Colorectal Cancer, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific